Table 1.
All | Males | Females | |||||
---|---|---|---|---|---|---|---|
N = 537 | N = 398 | N = 139 | p-value* |
||||
Variables |
N |
% |
N |
% |
N |
% |
|
Hypertensives | 43 | 8.0 | 28 | 7.0 | 15 | 10.8 | 0.16 |
Diabetics | 3 | 0.6 | 3 | 0.75 | 0 | 0 | NA |
Current smokers | 274 | 51.0 | 273 | 68.6 | 1 | 0.7 | <0.01 |
Ex-smokers | 62 | 11.6 | 60 | 15.1 | 2 | 1.4 | <0.01 |
Current alcohol users | 334 | 62.2 | 300 | 75.4 | 34 | 24.5 | <0.01 |
Analgesic users | 17 | 3.2 | 6 | 1.5 | 11 | 7.9 | <0.01 |
Former lead workers | |||||||
Evaluation 1 | 69 | 12.9 | 11 | 2.8 | 58 | 41.7 | <0.01 |
Evaluation 2 | 95 | 17.7 | 25 | 6.3 | 70 | 50.4 | <0.01 |
Evaluation 3 | 146 | 27.2 | 63 | 15.8 | 83 | 59.7 | <0.01 |
Mean | SD | Mean | SD | Mean | SD | p-value | |
Age, years | 42.0 | 9.3 | 39.7 | 9.1 | 48.6 | 6.4 | <0.01 |
Body mass index, kg/m2 | 23.1 | 3.0 | 22.5 | 2.6 | 24.6 | 3.4 | <0.01 |
Diastolic blood pressure, mm Hg | 76.4 | 11.8 | 76.5 | 11.5 | 76.2 | 12.6 | 0.85 |
Systolic blood pressure, mm Hg | 123.4 | 16.9 | 123.0 | 15.4 | 124.4 | 20.6 | 0.47 |
Blood lead level, μg/dL | |||||||
Evaluation 1 | 31.3 | 14.4 | 35.1 | 13.8 | 20.4 | 9.6 | <0.01 |
Evaluation 2 | 32.6 | 15.4 | 36.8 | 14.5 | 20.7 | 10.8 | <0.01 |
Evaluation 3 | 31.4 | 16.3 | 35.5 | 15.9 | 19.7 | 10.8 | <0.01 |
Tibia lead, μg Pb/g bone mineral | |||||||
Evaluation 1 | 35.0 | 37.8 | 37.6 | 42.2 | 27.6 | 19.3 | <0.01 |
Evaluation 2 | 33.0 | 39.4 | 36.2 | 43.6 | 23.5 | 20.5 | <0.01 |
Lead job duration, years | 8.8 | 6.3 | 9.2 | 6.7 | 7.6 | 4.8 | <0.01 |
BUN, mg/dL | |||||||
Evaluation 1 | 14.4 | 3.6 | 14.8 | 3.6 | 13.4 | 3.4 | <0.01 |
Evaluation 2 | 14.2 | 3.7 | 14.5 | 3.6 | 13.4 | 3.9 | <0.01 |
Evaluation 3 | 14.2 | 3.8 | 14.7 | 3.6 | 12.9 | 3.8 | <0.01 |
Serum creatinine, mg/dL | |||||||
Evaluation 1 | 0.89 | 0.14 | 0.94 | 0.11 | 0.74 | 0.10 | <0.01 |
Evaluation 2 | 0.88 | 0.14 | 0.92 | 0.12 | 0.75 | 0.12 | <0.01 |
Evaluation 3 | 0.87 | 0.14 | 0.91 | 0.12 | 0.75 | 0.11 | <0.01 |
Creatinine clearance, ml/min | |||||||
Evaluation 1 | 93.2 | 19.8 | 95.5 | 18.8 | 86.5 | 21.0 | <0.01 |
Evaluation 2 | 94.3 | 21.0 | 97.3 | 19.8 | 85.3 | 21.8 | <0.01 |
Evaluation 3 | 95.2 | 21.6 | 98.7 | 21.1 | 84.8 | 17.7 | <0.01 |
p-value for comparison between males and females using Chi-square or t-test, as appropriate